{"public_id":"co_4bd477297d18e56d75eddb73cd6805c5","status":"active","merged_into_public_id":null,"resolved_public_id":"co_4bd477297d18e56d75eddb73cd6805c5","name":"doxorubicin","description":"An anthracycline chemotherapeutic agent used here to induce and measure drug response.","aliases":[],"types":["drug"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":9330608,"title":"siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in P-glycoprotein expressing chondrosarcoma cells","citation_count":57,"url":"https://sah.borca.ai/papers/9330608"}],"claims":[{"public_id":"cl_d42d6ff7c41e548b029bd3e1be43429c","text":"siRNA knockdown or pharmacologic inhibition of Bcl-2, Bcl-xL, and XIAP enhances apoptosis of chemoresistant chondrosarcoma cells by up to 5.5 fold at 0.1 μmol and 5.5 fold at 1 μmol doxorubicin.","corpus_id":9330608,"url":"https://sah.borca.ai/claims/cl_d42d6ff7c41e548b029bd3e1be43429c"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_4bd477297d18e56d75eddb73cd6805c5","url":"https://sah.borca.ai/concepts/co_4bd477297d18e56d75eddb73cd6805c5"}